Agenus to participate at btig biotechnology conference

Lexington, mass., aug. 02, 2022 (globe newswire) -- agenus (nasdaq: agen), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced the company will attend the btig biotechnology conference. agenus will participate virtually and host one-on-one meetings with investors following its second quarter 2022 corporate update on the morning of august 9.
AGEN Ratings Summary
AGEN Quant Ranking